These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 8525631)

  • 1. Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism.
    Gerber SI; Belval BJ; Herold BC
    Virology; 1995 Dec; 214(1):29-39. PubMed ID: 8525631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
    Rux AH; Lou H; Lambris JD; Friedman HM; Eisenberg RJ; Cohen GH
    Virology; 2002 Mar; 294(2):324-32. PubMed ID: 12009874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface heparan sulfate.
    Azab W; Tsujimura K; Maeda K; Kobayashi K; Mohamed YM; Kato K; Matsumura T; Akashi H
    Virus Res; 2010 Jul; 151(1):1-9. PubMed ID: 20236610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein D homologs in herpes simplex virus type 1, pseudorabies virus, and bovine herpes virus type 1 bind directly to human HveC(nectin-1) with different affinities.
    Connolly SA; Whitbeck JJ; Rux AH; Krummenacher C; van Drunen Littel-van den Hurk S; Cohen GH; Eisenberg RJ
    Virology; 2001 Feb; 280(1):7-18. PubMed ID: 11162814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
    Argnani R; Boccafogli L; Marconi PC; Manservigi R
    Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of chimeric nectin-1(HveC)-related receptors to demonstrate that ability to bind alphaherpesvirus gD is not necessarily sufficient for viral entry.
    Geraghty RJ; Fridberg A; Krummenacher C; Cohen GH; Eisenberg RJ; Spear PG
    Virology; 2001 Jul; 285(2):366-75. PubMed ID: 11437670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins.
    Kouvatsis V; Argnani R; Tsitoura E; Arsenakis M; Georgopoulou U; Mavromara P; Manservigi R
    Virus Res; 2007 Jan; 123(1):40-9. PubMed ID: 16989918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.
    Pertel PE; Spear PG
    Virology; 1996 Dec; 226(1):22-33. PubMed ID: 8941319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry.
    Herold BC; Spear PG
    Virology; 1994 Aug; 203(1):166-71. PubMed ID: 8030274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties.
    Akula SM; Pramod NP; Wang FZ; Chandran B
    Virology; 2001 Jun; 284(2):235-49. PubMed ID: 11384223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of glycoproteins B, C and D on the conversion of virus-to-cell attachment from heparin sensitivity to resistance.
    Seck T; Koch O; Lingen M; Falke D
    Acta Virol; 1996 Sep; 40(4):179-85. PubMed ID: 9014007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparan sulphate and glycoprotein B.
    Herold BC; Visalli RJ; Susmarski N; Brandt CR; Spear PG
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1211-22. PubMed ID: 8207388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus: receptors and ligands for cell entry.
    Spear PG
    Cell Microbiol; 2004 May; 6(5):401-10. PubMed ID: 15056211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
    Da Costa XJ; Morrison LA; Knipe DM
    Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinoculation of heparan sulfate deficient cells enhances HSV-1 entry, but does not abolish the need for essential glycoproteins in viral fusion.
    Scanlan PM; Tiwari V; Bommireddy S; Shukla D
    J Virol Methods; 2005 Sep; 128(1-2):104-12. PubMed ID: 15908019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain.
    Adamiak B; Trybala E; Mardberg K; Johansson M; Liljeqvist JA; Olofsson S; Grabowska A; Bienkowska-Szewczyk K; Szewczyk B; Bergstrom T
    Virology; 2010 May; 400(2):197-206. PubMed ID: 20176392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
    Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
    Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
    Roller DG; Dollery SJ; Doyle JL; Nicola AV
    Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity.
    Novotny MJ; Parish ML; Spear PG
    Virology; 1996 Jul; 221(1):1-13. PubMed ID: 8661409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.